Why is Titan Biotech falling/rising?

As of 07-Jul, Titan Biotech Ltd's stock price is currently at 456.00, reflecting a decrease of 1.95 (-0.43%). The stock has experienced a trend reversal, falling after five consecutive days of gains. It touched an intraday low of Rs 445.1, which is a decline of 2.81%. In terms of performance, the stock has shown a 12.87% increase over the past week, while it has underperformed with a year-to-date decline of 37.77%. Despite a high management efficiency indicated by a return on equity (ROE) of 25.08% and a low debt-to-equity ratio, the company has declared negative results for the last three consecutive quarters, which has negatively impacted investor sentiment and contributed to the stock's recent decline.
In the broader market context, while the Sensex has shown a slight decline of 0.20% over the past week, Titan Biotech's short-term performance has significantly outpaced this benchmark. However, the stock has underperformed the market over the last year, generating a return of -23.90% compared to the BSE500's positive return of 1.74%. This underperformance, coupled with poor long-term growth indicators such as a low annual growth rate in net sales and operating profit, has led to a perception of the stock as an expensive valuation relative to its peers, further contributing to its downward price movement.